RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

Barak Capital vs Goat Funded Trader

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

BRKC

Barak Capital

GFTR

Goat Funded Trader

BARAK CAPITAL

METRIC

GOAT FUNDED TRADER

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

—

MAX FUNDING

—

MIN COST

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

BARAK CAPITAL DETAILS

STEPS: -phase

GOAT FUNDED TRADER DETAILS

STEPS: -phase
MARKETS: Forex, Futures

Barak Capital PROS

+Based in South Africa, providing regional access for African traders
+Listed on PropDNA, giving traders a discovery reference point
+Defined country presence provides geographic transparency
+Established enough to be catalogued for trader comparison

Barak Capital CONS

−No data provided on profit split, max funding, or challenge cost
−No trading conditions such as drawdown, profit target, or payout terms are available
−Traders cannot meaningfully compare this firm to industry averages without data

Goat Funded Trader PROS

+Covers both Forex and Futures markets, offering access to two distinct and liquid trading environments.
+No further data is available to substantiate additional pros at this time.
+No funding or cost data is available to compare against industry benchmarks.
+No profit split or payout data exists to evaluate trader compensation.

Goat Funded Trader CONS

−Almost no operational data is available for Goat Funded Trader beyond market types.
−Note: as a futures firm, drawdown may be expressed in dollar terms and cannot be compared to the 7.9% CFD average.
−No profit split, challenge cost, or funding data is provided for any meaningful industry comparison.

PROPDNA VERDICT